| Date Filed | Type | Description |
| 06/15/2023 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 03/17/2023 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $22.01, valued at
$2.2k
Exercised 100 options to buy
@ $1.24, valued at
$124 |
|
| 01/24/2023 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 144,000 options to buy
@ $22.47, valued at
$3.2M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 40,000 shares
@ $22.0142, valued at
$880.6k
Exercised 40,000 options to buy
@ $1.24, valued at
$49.6k
|
|
| 08/31/2022 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 14,003 shares
@ $22, valued at
$308.1k
Sold 62,498 shares
@ $22.1182, valued at
$1.4M
Sold 3,499 shares
@ $22.0798, valued at
$77.3k
Exercised 14,003 options to buy
@ $0.53, valued at
$7.4k
Exercised 27,740 options to buy
@ $0.53, valued at
$14.7k
Exercised 34,758 options to buy
@ $1.24, valued at
$43.1k
Exercised 3,499 options to buy
@ $1.24, valued at
$4.3k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 115,500 options to buy
@ $14.22, valued at
$1.6M
|
|
| 11/22/2021 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $27.8887, valued at
$697.2k
Exercised 24,396 options to buy
@ $1.24, valued at
$30.3k
Exercised 604 options to buy
@ $0.53, valued at
$320.1 |
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Converted 16,751 shares
@ $0
Converted 35,337 preferred shares
@ $0 |
|
| 06/11/2020 |
3
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 3 on Avidity Biosciences, Inc. |
| 06/05/2020 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 14,777 options to buy
@ $26.53, valued at
$392k
|
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |